Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2010

Open Access 01-12-2010 | Case report

Post-transplant lymphoproliferative disorder involving the ovary as an initial manifestation: a case report

Authors: Takamitsu Inoue, Shigeru Satoh, Mitsuru Saito, Yohei Horikawa, Norihiko Tsuchiya, Tomonori Habuchi

Published in: Journal of Medical Case Reports | Issue 1/2010

Login to get access

Abstract

Introduction

Because the normal ovary is assumed to be devoid of lymphoid tissue, it is unusual for it to be an initial manifestation of malignant lymphoma. This case is the first report, to our knowledge, of post-transplant lymphoproliferative disorder involving the ovary as an initial manifestation.

Case presentation

Twenty-nine weeks after a living renal transplantation, a 38-year-old Japanese female, whose ethnic origin was Asian, presented with abdominal pain and a chronic high fever. Computed tomography revealed a right ovarian tumor and liver metastases. The patient underwent oophrectomy based on the clinical diagnosis of liver metastasis from the primary ovarian tumor. The pathological diagnosis was Epstein-Barr Virus-associated post-transplant lymphoproliferative disorder. While ovarian malignant lymphoma has a poor prognosis, complete remission of liver involvement in this case was achieved only with a reduction of immunosuppressants.

Conclusion

Clinicians should remember that malignant lymphoma could initially involve the ovary, especially if the patient is immunosuppressed after transplantation therapy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tsai DE, Hardy CL, Tomaszewski JE, Kotloff RM, Oltoff KM, Somer BG, Schuster SJ, Porter DL, Montone KT, Stadtmauer EA: Reduction in immunosuppression as initial therapy for post-transplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients. Transplantation. 2001, 71: 1076-1088. 10.1097/00007890-200104270-00012.CrossRefPubMed Tsai DE, Hardy CL, Tomaszewski JE, Kotloff RM, Oltoff KM, Somer BG, Schuster SJ, Porter DL, Montone KT, Stadtmauer EA: Reduction in immunosuppression as initial therapy for post-transplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients. Transplantation. 2001, 71: 1076-1088. 10.1097/00007890-200104270-00012.CrossRefPubMed
2.
go back to reference Monterroso V, Jaffe ES, Merino MJ, Medeiros LJ: Malignant lymphomas involving the ovary. A clinicopathologic analysis of 39 cases. Am J Surg Pathol. 1993, 17: 154-170. 10.1097/00000478-199302000-00007.CrossRefPubMed Monterroso V, Jaffe ES, Merino MJ, Medeiros LJ: Malignant lymphomas involving the ovary. A clinicopathologic analysis of 39 cases. Am J Surg Pathol. 1993, 17: 154-170. 10.1097/00000478-199302000-00007.CrossRefPubMed
3.
go back to reference Chorlton I, Norris HJ, King FM: Malignant reticuloendothelial disease involving the ovary as a primary manifestation: a series of 19 lymphomas and 1 granulocytic sarcoma. Cancer. 1974, 34: 397-407. 10.1002/1097-0142(197408)34:2<397::AID-CNCR2820340225>3.0.CO;2-0.CrossRefPubMed Chorlton I, Norris HJ, King FM: Malignant reticuloendothelial disease involving the ovary as a primary manifestation: a series of 19 lymphomas and 1 granulocytic sarcoma. Cancer. 1974, 34: 397-407. 10.1002/1097-0142(197408)34:2<397::AID-CNCR2820340225>3.0.CO;2-0.CrossRefPubMed
4.
go back to reference Fox H, Langley FA, Govan AD, Hill AS, Bennett MH: Malignant lymphoma presenting as an ovarian tumour: a clinicopathological analysis of 34 cases. Br J Obstet Gynaecol. 1988, 95: 386-390.CrossRefPubMed Fox H, Langley FA, Govan AD, Hill AS, Bennett MH: Malignant lymphoma presenting as an ovarian tumour: a clinicopathological analysis of 34 cases. Br J Obstet Gynaecol. 1988, 95: 386-390.CrossRefPubMed
5.
go back to reference Shapiro R, Nalesnik M, McCauley J, Fedorek S, Jordan ML, Scantlebury VP, Jain A, Vivas C, Hakala TR, Simmons RL, Fung JJ, Starzl TE: Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation. 1999, 68: 1851-1854. 10.1097/00007890-199912270-00006.CrossRefPubMedPubMedCentral Shapiro R, Nalesnik M, McCauley J, Fedorek S, Jordan ML, Scantlebury VP, Jain A, Vivas C, Hakala TR, Simmons RL, Fung JJ, Starzl TE: Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation. 1999, 68: 1851-1854. 10.1097/00007890-199912270-00006.CrossRefPubMedPubMedCentral
6.
go back to reference Smith JM, Rudser K, Gillen D, Kestenbaum B, Seliger S, Weiss N, McDonald RA, Davis CL, Stehmen-Breen C: Risk of lymphoma after renal transplantation varies with time: an analysis of the United States Renal Data System. Transplantation. 2006, 81: 175-180. 10.1097/01.tp.0000188687.18972.a8.CrossRefPubMed Smith JM, Rudser K, Gillen D, Kestenbaum B, Seliger S, Weiss N, McDonald RA, Davis CL, Stehmen-Breen C: Risk of lymphoma after renal transplantation varies with time: an analysis of the United States Renal Data System. Transplantation. 2006, 81: 175-180. 10.1097/01.tp.0000188687.18972.a8.CrossRefPubMed
7.
go back to reference Shahinian VB, Muirhead N, Jevnikar AM, Leckie SH, Khakhar AK, Luke PP, Rizkalla KS, Hollomby DJ, House AA: Epstein-Barr virus seronegativity is a risk factor for late-onset post-transplant lymphoproliferative disorder in adult renal allograft recipients. Transplantation. 2003, 75: 851-856. 10.1097/01.TP.0000055098.96022.F7.CrossRefPubMed Shahinian VB, Muirhead N, Jevnikar AM, Leckie SH, Khakhar AK, Luke PP, Rizkalla KS, Hollomby DJ, House AA: Epstein-Barr virus seronegativity is a risk factor for late-onset post-transplant lymphoproliferative disorder in adult renal allograft recipients. Transplantation. 2003, 75: 851-856. 10.1097/01.TP.0000055098.96022.F7.CrossRefPubMed
8.
go back to reference Dao AH: Malignant lymphoma of the ovary: report of a case successfully managed with surgery and chemotherapy. Gynecol Oncol. 1998, 70: 137-140. 10.1006/gyno.1998.5033.CrossRefPubMed Dao AH: Malignant lymphoma of the ovary: report of a case successfully managed with surgery and chemotherapy. Gynecol Oncol. 1998, 70: 137-140. 10.1006/gyno.1998.5033.CrossRefPubMed
9.
go back to reference Blaes AH, Peterson BA, Bartlett N, Dunn DL, Morrison VA: Rituximab therapy is effective for post-transplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial. Cancer. 2005, 104: 1661-1667. 10.1002/cncr.21391.CrossRefPubMed Blaes AH, Peterson BA, Bartlett N, Dunn DL, Morrison VA: Rituximab therapy is effective for post-transplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial. Cancer. 2005, 104: 1661-1667. 10.1002/cncr.21391.CrossRefPubMed
10.
go back to reference Trappe R, Riess H, Babel N, Hummel M, Lehmkuhl H, Jonas S, Anagnostopoulos I, Papp-Vary M, Reinke P, Hetzer R, Dörken B, Oertel S: Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab. Transplantation. 2007, 83: 912-918. 10.1097/01.tp.0000258647.50947.78.CrossRefPubMed Trappe R, Riess H, Babel N, Hummel M, Lehmkuhl H, Jonas S, Anagnostopoulos I, Papp-Vary M, Reinke P, Hetzer R, Dörken B, Oertel S: Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab. Transplantation. 2007, 83: 912-918. 10.1097/01.tp.0000258647.50947.78.CrossRefPubMed
Metadata
Title
Post-transplant lymphoproliferative disorder involving the ovary as an initial manifestation: a case report
Authors
Takamitsu Inoue
Shigeru Satoh
Mitsuru Saito
Yohei Horikawa
Norihiko Tsuchiya
Tomonori Habuchi
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2010
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-4-184

Other articles of this Issue 1/2010

Journal of Medical Case Reports 1/2010 Go to the issue